With the Veris Cancer Care Platform, cancer care teams at the New Jersey Cancer Care, PA can now review patients’ physiologic and clinical data in real time and deliver personalized care.
WHY IT MATTERS
Today, NJCC and Veris Health, a subsidiary of New York-based PAVmed Digital Health, announced…
Source: Healthcareitnews.com and Read More
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
